• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER BLOOD CONTROL TECHNOLOGY 22GA; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER BLOOD CONTROL TECHNOLOGY 22GA; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 309659
Device Problem Contamination (1120)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/19/2022
Event Type  malfunction  
Manufacturer Narrative
A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported while using bd insyte¿ autoguard¿ bc shielded iv catheter blood control technology 22ga foreign matter was found.There was no report of patient impact.The following information was provided by the initial reporter: some of the syringes have had what looks like a residue in the very tip.We took a q-tip to the tip of the syringe and it didn't appear that anything came off on it, so we are thinking it is just part of the plastic, but the provider and nursing staff are wanting to confirm for safety purposes.".
 
Manufacturer Narrative
Investigation summary: two photos were provided to our quality team for investigation.Through visual inspection, it was observed that a small amount of plastic extending out of the tip of the barrel.The reported defect could not be verified from the photos received.A physical sample is required for a more thorough evaluation and potential root cause determination.A device history record review was completed for provided lot number 2284476.A review showed no rejected inspections or quality issues during the production that could have contributed to the reported defect.
 
Event Description
It was reported while using bd insyte¿ autoguard¿ bc shielded iv catheter blood control technology 22ga foreign matter was found.There was no report of patient impact.The following information was provided by the initial reporter: some of the syringes have had what looks like a residue in the very tip.We took a q-tip to the tip of the syringe and it didn't appear that anything came off on it, so we are thinking it is just part of the plastic, but the provider and nursing staff are wanting to confirm for safety purposes.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER BLOOD CONTROL TECHNOLOGY 22GA
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key16120557
MDR Text Key308712258
Report Number1710034-2022-00904
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier00382903810239
UDI-Public(01)00382903810239
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K110771
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number309659
Device Lot Number2284476
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/19/2022
Initial Date FDA Received01/09/2023
Supplement Dates Manufacturer Received02/09/2023
Supplement Dates FDA Received03/01/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/11/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-